By now, we all know that exercise is not just good for our body, but also our brain. Exercise, as it is known, releases ...

Parents try everything to influence their children. But new research suggests brothers and sisters have their own profound ...

Boehringer Ingelheim today announces the start of the JADE Phase II clinical study (NCT06769048), investigating the efficacy and safety of BI 1584862 as a potential first-in-class treatment for ...

With this ruling, Avadel can seek and be granted FDA approval for LUMRYZ in Idiopathic Hypersomnia - - Federal Circuit decision permits new clinical trials and further development of LUMRYZ™ for the ...

Neurocrine Biosciences announces new survey revealing need for routine screening and earlier diagnosis for people living with tardive dyskinesia: San Diego Tuesday, May 6, 2025, 1 ...

March 31, 2025, and an updated cash runway guidance into 2029; commercial readiness activities ongoing Over 300 patients enrolled in darovasertib and crizotinib registrational 1L HLA-A2-negative MUM ...

Change is our only constant in this world, and these skills provide a strong foundation for thriving in an ever-changing environment.

Wondering about the blue Adderall pill? Learn about its side effects in females and males, plus the top OTC Adderall ...

The Trump administration revealed in a court filing that it will continue the Biden administration’s defense of the FDA’s ...

On his first day, President Donald Trump issued a host of executive orders to reverse many of former President Joe Biden’s ...

First quarter 2025 total revenues increased 4% to $149.8 million, compared to the same period in 2024. First quarter 2025 total revenues excluding Trokendi XR ® and Oxtellar XR ® net sales (non-GAAP) ...

Q1 2025 Earnings Conference Call May 6, 2025 8:30 AM ETCompany ParticipantsJeannine Feyen – Director-CommunicationsJon Cohen ...